Advantage of immunochemical fecal occult blood test in screening for colorectal cancer;Apport des tests immunologiques de recherche de sang occulte dans les selles pour le dépistage du cancer colorectal

Bulletin du Cancer

Volumn 92, Issue 10, 2005, Pages 885-890

  Launoy, Guy ^a   Berchi, C ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Colorectal cancer; Immunochemical test; Screening

Indexed keywords

HEMOGLOBIN;

AUTOMATION; CANCER SCREENING; CHINESE; COLORECTAL CANCER; COST; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; HUMAN; IMMUNOCHEMISTRY; INDUSTRIALIZATION; ITALY; JAPAN; MASS SCREENING; OCCULT BLOOD TEST; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; UNITED STATES;

COLORECTAL NEOPLASMS; FRANCE; GUAIAC; HEMOGLOBIN A; HUMANS; IMMUNOLOGIC TESTS; INDICATORS AND REAGENTS; OCCULT BLOOD; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 27744571899     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Remontet L, Esteve J, Bouvier AM, et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publ 2003; 51: 3-30.
2. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinene T, Esteve J. Survisal of cancer patients in Europe. The Eurocare study. IARC scientific publications n° 132. Lyon : IARC, 1995.
3. Mandel JS, Bond JH, Church TR, et al. reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328: 1365-71.
4. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-7.
5. Kronbörg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-71.
6. Faivre J, Dancourt V, Lejeune C, Tazi M, Lamour J, Gérard D, et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 2004; 126: 1674-80.
7. Duffy SW, Esteve J, Hill C, Day NE. Introduction and brief history of cancer screening evaluation techniques. In: Duffy SW, ed. Quantitative methods for the evaluation of cancer screening. New York, 2001.
8. Hakama M. Trends in the incidence of cervical cancer in the Nordic countries. In: Magnus K, ed. Trends in cancer incidence. Causes and practical implications. Washington: Hemisphere, 1982.
9. Blanks RG, Moss SM, McGahan CE. Effect of NHS breast cancer screening programme on mortality from breast cancer in England and Wales. Comparison of observed and predicted mortality. Br Med J 2000; 321: 665-9.
10. Launoy G, Smith TC, Duffy SW, Bouvier V. Colorectal cancer mass screening: estimation of fecal occult blood test sensitivity taking into account cancer mean sojourn time. Int J Cancer 1997; 73: 220-4.
11. Launoy G, Veret JL, Richir B, et al. Involvement of general practitioners in mass screening for colorectal cancer. Eur J Cancer Prev 1993; 3: 229-32.
12. Berchi C, Launoy G, Dupuis JM. Analyse des motivations des médecins généralistes pour la promotion du dépistage organisé du cancer colorectal en France. Gastroenterol Clin Biol 2004; 28: 213.
13. Bedenne L, Durand G, Faivre J, Milan C, Boutron MC, Arveux P, et al. Résultats préliminaires d'une campagne de dépistage de masse du cancer colorectal. Gastroenterol Clin Biol 1990; 14: 140-5.
14. Tazi MA, Faivre J, Dassonville F, Lamour J, Milan C, Durand G. Participation in faecal occult blood screening for colorectal cancer in a well defined French population: results of five screening rounds from 1988 to 1996. J Med Screen 1997; 4: 147-51.
15. Launoy G, Herbert C, Vallee JP, et al. Le dépistage de masse du cancer colorectal en France. Expérience auprès de 165 000 personnes dans le Calvados. Gastroenterol Clin Biol 1996; 20: 228-36.
16. Launoy G, Duffy SW, Prevost TC, Bouvier V. Dépistage des cancers, sensibilité du test et sensibilité du programme de dépistage. Rev Epidemiol Santé Publ 1998; 46: 420-6.
17. Allison JE, Tekawa IS, Ransom LJ, Adrain AL. A comparison of fecal occult-blood tests for colorectal cancer screening. N Engl J Med 1996; 334: 155-9.
18. Castiglione G, Sala P, Ciatto S, Grazzini G, Mazzota A, Rosseti C, et al. Comparative analysis of results of guaiac and immunochemical tests for faecal occult blood in colorectal cancer screening in two oncological institutions. Eur J Cancer Prev 1994; 3: 399-405.
19. Saito H, Soma Y, Koeda J, Wada T, Kawaguchi H, Sobue T, et al. Reduction in risk of mortality from colorectal cancer by fecal ocult blood screening with immunochemical hemagglutination test. A case-control study. Int J Cancer 1995; 61: 465-9.
20. Allison JE. Faecal occult blood testing for colorectal cancer. Aliment Pharmacol Ther 1998; 12: 1-10.
21. Sieg A, Hertel A, John MR, Lüthgens K, Schmidt-Gayk H. Screening for colorectal cancer with a new immunological human faecal haemoglobin and albumin test. Eur J Cancer Prev 1998; 7: 279-85.
22. Zappa M, Catiglione G, Paci E, Grazzini G, Rubeca T, Turco P, et al. Measuring interval cancers in population-based screening using different assays of fecal occult blood testing: the district of Florence experience. Int J Cancer 2001; 92: 151-4.
23. Launoy G, Bertrand H, Berchi C, Tabourdet V, Guizard AV, Bouvier V, et al. Evaluation of an immunochemical faecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population. Int J Cancer 2005; 115: 493-6.
24. Berchi C, Bouvier V, Reaud JM, Launoy G. Cost-effectiveness analysis of two strategies for mass screening of colorectal cancer in France. Health Econ 2003; 13: 227-38.
25. Wong WM, Lam SK, Cheung KL, Tong TS, Rozen P, Young GP, et al. Evaluation of an automated immunochemical fecal occult blood. Cancer 2003; 15: 2420-4.
26. Castiglione G, Grazzini G, Miccinesi G, Rubeca T, Sani C, Turco P, et al. Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood. J Med Screen 2002; 9: 99-103.
27. Segnan N, Senore C, Andreoni B, Arrigoni A, Bisanti L, Cardelli A, et al. Randomized trial of different screening strategies for colorectal cancer patient response rate and detection rates. J Natl Cancer Inst 2005; 97: 347-57.